QS Investors, LLC - IMMUNOMEDICS INC ownership

IMMUNOMEDICS INC's ticker is IMMU and the CUSIP is 452907108. A total of 212 filers reported holding IMMUNOMEDICS INC in Q3 2019. The put-call ratio across all filers is 0.35 and the average weighting 0.4%.

Quarter-by-quarter ownership
QS Investors, LLC ownership history of IMMUNOMEDICS INC
ValueSharesWeighting
Q2 2020$160,000
+162.3%
4,5100.0%0.00%
+100.0%
Q1 2020$61,000
-33.7%
4,5100.0%0.00%0.0%
Q4 2019$92,000
+53.3%
4,5100.0%0.00%0.0%
Q3 2019$60,000
-4.8%
4,5100.0%0.00%0.0%
Q2 2019$63,000
-27.6%
4,5100.0%0.00%0.0%
Q1 2019$87,000
+33.8%
4,5100.0%0.00%0.0%
Q4 2018$65,000
-30.9%
4,5100.0%0.00%0.0%
Q3 2018$94,000
-12.1%
4,5100.0%0.00%0.0%
Q2 2018$107,0004,5100.00%
Other shareholders
IMMUNOMEDICS INC shareholders Q3 2019
NameSharesValueWeighting ↓
ACUTA CAPITAL PARTNERS, LLC 4,750,000$112,433,00020.02%
Avoro Capital Advisors LLC 17,714,461$419,301,00016.14%
Foresite Capital Management III, LLC 2,541,729$60,163,00012.96%
Foresite Capital Management IV, LLC 1,231,543$29,151,0009.94%
Ghost Tree Capital, LLC 1,250,000$29,588,0008.71%
NEXTHERA CAPITAL LP 1,329,104$31,460,0004.87%
RA Capital Management 3,119,778$73,845,0004.79%
DLD Asset Management, LP 2,682,100$63,458,0004.78%
Palo Alto Investors LP 4,803,364$113,696,0004.54%
DLD Asset Management, LP 2,411,600$57,058,0004.30%
View complete list of IMMUNOMEDICS INC shareholders